Improving the assessment of quality of life in the clinical care of myeloma patients: The development and validation of the Myeloma Patient Outcome Scale (MyPOS)

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Osborne, Thomas R ^a   Ramsenthaler, Christina ^a   Schey, Stephen A ^b   Siegert, Richard J ^a,c   Edmonds, Polly M ^a,b   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Cancer; Haematology; Multiple myeloma; Oncology; Outcome assessment; Psychometrics; Quality of life

Indexed keywords

ADULT; AGED; ENGLAND; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PATHOLOGY; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PSYCHOMETRICS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84928037609     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1261-6     Document Type: Article

References (43)

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11 [Internet] [http://globocan.iarc.fr]
2. Parkin M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
3. Gulbrandsen N, Wisloff F, Brinch L, Carlson K, Dahl IM, Gimsing P, et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol. 2001;18(1):65-77.
4. Sherman AC. Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant. 2004;33:955-62.
5. Uyl-de Groot CA, Buijt I, Gloudemans IJM, Ossenkoppele GJ, Berg HP, Huijgens PC. Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol. 2005;74(2):136-43.
6. Sirohi B, Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer. 2006;42:1671-8.
7. Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(1):12-20.
8. Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur J Haematol. 2012;89(6):436-57.
9. Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe E, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43(11):1670-9.
10. Stead ML, Brown JM, Velikova G, Kaasa S, Wisloff F, Child JA, et al. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol. 1999;104(3):605-11.
11. Wisloff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, et al. Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol. 1996;92(3):604-13.
12. Wagner LI, Robinson DJ, Weiss M, Katz M, Greipp P, Fonseca R, et al. Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. J Pain Symptom Manage. 2012;43(6):1094-104.
13. Osborne TR, Ramsenthaler C, de Wolf-Linder S, Schey SA, Siegert RJ, Edmonds PM, et al. What matters most to people with multiple myeloma? A qualitative study of views on quality of life. BMC Cancer. 2014;14:496.
14. Palliative Care Outcome Scale. [http://www.pos-pal.org]
15. Kvam AK, Fayers P, Wisloff F. What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. Eur J Haematol. 2010;84(4):345-53.
16. Beatty PC, Willis GB. Research synthesis: the practice of cognitive interviewing. Public Opin Quart. 2007;71(2):287-311.
17. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263-78.
18. Willis GB. Cognitive interviewing in practice: think-aloud, verbal probing and other techniques. In: Cognitive interviewing: a tool for improving questionnaire design. London: Sage Publications; 2005. p. 42-63.
19. Tourangeau R. Cognitive sciences and survey methods. In: Jabine TB, Straf ML, Tanur JM, Tourangeau R, editors. Cognitive aspects of survey methodology: building a bridge between disciplines. Washington, DC: National Academy Press; 1984. p. 73-101.
20. Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12:229-38.
21. Willis GB. Analyzing and documenting cognitive interview results. In: Cognitive interviewing: a tool for improving questionnaire design. London: Sage Publications; 2005. p. 151-74.
22. Nunally JO. Psychometric theory. New York: McGraw-Hill; 1978.
23. Guilford JP. Psychometric methods. New York: McGraw-Hill; 1956.
24. Tabachnick BG, Fidell LS. Chapter 13: principal components and factor analysis. In: Tabachnick BG, Fidell LS, editors. Using multivariate statistics. London: Pearson; 2012.
25. Bartlett MS. Tests of significance in factor analysis. Br J Psychol. 1950;3(Part II):77-85.
26. Kaiser HF. A second-generation little jiffy. Psychometrika. 1970;35(4):401-15.
27. Kaiser HF. Little Jiffy, Mark IV. Educ Psychol Meas. 1974;34:111-7.
28. Cattell RB. The scree test for the number of factors. Multivar Behav Res. 1966;1(2):245-76.
29. O'Connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer's MAP test. Behav Res Methods Instrum Comput. 2000;32:396-402.
30. Velicer WF, Jackson DN. Component analysis versus common factor-analysis - Some further observations. Multivar Behav Res. 1990;25(1):97-114.
31. Fayers PM, Machin D. Scores and measurements: vaidity, reliability, sensitivity. In: Quality of life: the assessment, analysis and interpretation of patient reported outcomes. 2nd ed. Chichester: Wiley and Sons Ltd; 2007. p. 77-108.
32. Johnson C, Aaronson N, Blazeby JM, Bottomley A, Fayers P, EORTC Quality of Life Group, et al. Guidelines for developing questionnaire modules (4th Edition). Available online at http://groupseortcbe/qol/sites/default/files/archives/guidelines_for_developing_questionnaire-_final.pdf 2011.
33. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Field testing: item reduction and data structure. In: Measurement in medicine. Cambridge, UK: Cambridge University Press; 2011. p. 65-95.
34. Fayers P, Aaronson NK, Bjordal K, Curran D, and Groenvold M on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 Scoring Manual (Third edition). Brussels: EORTC Quality of Life Group; 2001.
35. Dahan J, Auerbach CF. A qualitative study of the trauma and posttraumatic growth of multiple myeloma patients treated with peripheral blood stem cell transplant. Pall Supp Care. 2006;4(4):365-87.
36. Maher K, De Vries K. An exploration of the lived experiences of individuals with relapsed Multiple Myeloma. Eur J Cancer Care. 2011;20:267-75.
37. Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Living with multiple myeloma: experiences of patients and their informal caregivers. Supp Care Cancer. 2011;19(1):101-11.
38. Potrata B, Cavet J, Blair S, Howe T, Molassiotis A. Understanding distress and distressing experiences in patients living with multiple myeloma: an exploratory study. Psycho-Oncol. 2011;20(2):127-34.
39. Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol. 1993;78:98-104.
40. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99-103.
41. Higginson IJ, Carr A. Using quality of life measures in the clinical setting. BMJ. 2001;322(7297):1297-300.
42. Osoba D. Translating the science of patient-reported outcomes assessment into clinical practice. J Natl Cancer Inst Monogr. 2007;37:5-11.
43. Fortune-Greeley AK, Flynn KE, Jeffery DD, Williams MS, Keefe FJ, Reeve BB, et al. Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res. 2009;18(8):1085-93.